Dupixent Cancer Lawyers Reviewing Lymphoma Lawsuits Over Hidden Risks
The lawyers at Saiontz & Kirk are now reviewing Dupixent cancer lawsuits for individuals diagnosed with cutaneous T-cell lymphoma (CTCL), Sézary syndrome, or other rare T-cell lymphomas after receiving Dupixent (dupilumab) injections for eczema, asthma, or related conditions. While Sanofi and Regeneron have promoted their drug… Read More
